Laboratorios Farmaceúticos Rovi SA (LABFF)
67.17
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Laboratorios Farmaceúticos Rovi EPS Diluted (Quarterly) : 1.705 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.705 |
| March 31, 2026 | 0.2168 |
| December 31, 2025 | 0.9711 |
| September 30, 2025 | 1.326 |
| June 30, 2025 | 0.4794 |
| March 31, 2025 | 0.3724 |
| December 31, 2024 | 0.4878 |
| September 30, 2024 | 1.499 |
| June 30, 2024 | 0.5926 |
| March 31, 2024 | 0.3134 |
| December 31, 2023 | 1.069 |
| September 30, 2023 | 1.064 |
| June 30, 2023 | 0.3913 |
| March 31, 2023 | 0.9541 |
| December 31, 2022 | 1.494 |
| September 30, 2022 | 0.802 |
| June 30, 2022 | 0.5498 |
| March 31, 2022 | 1.085 |
| December 31, 2021 | 1.128 |
| September 30, 2021 | 1.019 |
| June 30, 2021 | 0.5916 |
| March 31, 2021 | 0.5183 |
| December 31, 2020 | 0.3063 |
| September 30, 2020 | 0.3636 |
| June 30, 2020 | 0.3116 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2769 |
| December 31, 2019 | 0.1717 |
| September 30, 2019 | 0.2915 |
| June 30, 2019 | 0.188 |
| March 31, 2019 | 0.1414 |
| December 31, 2018 | 0.0462 |
| September 30, 2018 | 0.1911 |
| June 30, 2018 | 0.0172 |
| March 31, 2018 | 0.1704 |
| December 31, 2017 | 0.0053 |
| September 30, 2017 | 0.0297 |
| June 30, 2017 | 0.2093 |
| March 31, 2017 | 0.1359 |
| December 31, 2016 | 0.097 |
| September 30, 2016 | 0.0784 |
| June 30, 2016 | 0.192 |
| March 31, 2016 | 0.2074 |
| December 31, 2015 | 0.0766 |
| September 30, 2015 | 0.0667 |
| June 30, 2015 | 0.1549 |
| March 31, 2015 | 0.1461 |
| December 31, 2014 | 0.1124 |
| September 30, 2014 | 0.13 |
| June 30, 2014 | 0.248 |
| March 31, 2014 | 0.1625 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Almirall SA | 0.00 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 87.12M |
| Revenue (Quarterly) | 222.85M |
| Total Expenses (Quarterly) | 135.65M |
| Enterprise Value | 3.431B |
| Gross Profit Margin (Quarterly) | 63.56% |
| Profit Margin (Quarterly) | 39.09% |
| Earnings Yield | 6.28% |
| Operating Earnings Yield | 5.12% |
| Normalized Earnings Yield | 6.278 |